10 Mar 2016
Myology 2016, 5th edition from March 14 to March 18 in Lyon
The 5th edition of the International Congress of Myology organised by AFM-Téléthon is taking place at the Palais des Congrès in Lyon, from March 14 to March 18 with the participation of over 800 international experts.
This event is the key point of international myology in 2016, 30 years exactly after the discovery of the gene involved in Duchenne Muscular Dystrophy, made public in 1986 at the Tours Congress, also organised by the Association.
Myology, spearhead of advanced therapies
In 30 years, research has moved from a stuttering science to the emergence of the first therapeutic solutions for neuromuscular diseases. Over 70 myology experts from the 5 continents will be presenting their latest work at Myology 2016. Nearly 450 posters will be displayed to delegates. 10 plenary sessions and 14 symposia will focus on current issues of myology such as stem cells in muscular development, neuromuscular interactions, therapeutic approaches, particularly the most advanced (gene therapy, exon skipping, pharmacogénomics...), the latest progress in therapeutics for the heart, a vital muscle...
Highlights de Myology 2016
Mon, March 14, 6pm: Opening Lecture celebrating the 30th anniversary of the discovery of the gene involved in Duchenne Muscular Distrophy by Kenneth Fischbeck (one of the publication' signatories)
Tue, March 15: Fundamental muscle biology and neuromuscular junction
Wed, March 16 and Thu, March 17: Focus on the therapeutics under trial or being developed for neuromuscular diseases
Fri, March 18: Focus on the heart and on the advanced therapies being developed (cell therapy, gene therapy) ; Closing conference on the advanced technology Crispr9 and its practical application on Duchenne Muscular Distrophy.